Over-the-counter medication · Nasal Corticosteroid
triamcinolone nasal
Also sold as Nasacort. Nasacort temporarily relieves symptoms of hay fever and other upper respiratory allergies.
Data updated 2026-05-15
- OTC
- Availability
triamcinolone nasal (Nasacort) is an over-the-counter Nasal Corticosteroid. Nasacort temporarily relieves symptoms of hay fever and other upper respiratory allergies.
Nasacort is a nasal spray that helps relieve allergy symptoms. It contains triamcinolone, a type of medicine called a nasal corticosteroid.
Verify with FDA → · CMS NADAC pricing →
What it does
Nasacort temporarily relieves symptoms of hay fever and other upper respiratory allergies.
Common side effects
No common side effects listed.
Key warnings
The growth rate of some children may be slower while using this product.
The sections below are summarized in plain English from triamcinolone nasal's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Nasacort contains a corticosteroid that reduces inflammation in your nose. This helps to relieve allergy symptoms like stuffiness and sneezing. It works directly in the nose to target the source of your symptoms.
Serious Warnings
The growth rate of some children may be slower while using this product. If a child needs to use this spray for longer than two months a year, talk to their doctor.
Common Questions
How often should adults and children over 12 use this?
How often should children 6 to under 12 use this?
How often should children 2 to under 6 use this?
Can children under 2 use this?
What should I do if my allergy symptoms don't improve?
Can I spray this in my eyes or mouth?
What do I do before using a new bottle?
What do I do if I haven't used the spray for over 2 weeks?
Do I need to shake the bottle?
Can I use this for a cold?
What drug class is triamcinolone nasal?
What pregnancy or breastfeeding source fields are listed for triamcinolone nasal?
Related Medications in Nasal Corticosteroid
Other drugs grouped near triamcinolone nasal - same-class peers and common alternatives.
azelastine
Astelin, Astepro
Azelastine nasal spray is an antihistamine medicine.
Compare with triamcinolone nasal →
budesonide nasal
Rhinocort
Rhinocort is a nasal spray that helps relieve allergy symptoms.
Compare with triamcinolone nasal →
cetirizine
Zyrtec
Cetirizine (Zyrtec) is an antihistamine medicine.
Compare with triamcinolone nasal →
chlorpheniramine
Chlor-Trimeton
Chlorpheniramine is an antihistamine medicine.
Compare with triamcinolone nasal →
ciclesonide nasal
Omnaris, Zetonna
Omnaris Nasal Spray is a medicine that helps treat allergy symptoms in your nose.
Compare with triamcinolone nasal →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Pain Relievers Compared
NSAIDs vs acetaminophen, which OTC pain reliever to use
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
What the FDA Data Shows for triamcinolone nasal
The FDA label for triamcinolone nasal (sold under brand names such as Nasacort) classifies it as an over-the-counter product in the Nasal Corticosteroid class. Nasacort temporarily relieves symptoms of hay fever and other upper respiratory allergies. Labeling covers dosing, contraindications, and monitoring requirements derived from clinical trials.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. Interaction data is drawn directly from FDA-approved prescribing information. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: April 23, 2025
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages